View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
December 15, 2017

M&As this week: Allergan, Philab Holdings

Ireland-based pharmaceutical company Allergan, through its subsidiaries Allergan Sales and Celestial Merger Sub, has agreed to acquire US-based development-stage biopharmaceutical company Repros Therapeutics.

Ireland-based pharmaceutical company Allergan, through its subsidiaries Allergan Sales and Celestial Merger Sub, has agreed to acquire US-based development-stage biopharmaceutical company Repros Therapeutics.

Celestial Merger will purchase all outstanding shares of common stock of Repros Therapeutics for $0.67 a share, under the agreement.

The transaction was announced in December and will be closed in the first quarter of 2018.

Philippines-based life science equipment and services provider Philab Holdings plans to purchase a 67% share in pharmaceutical firm Sydenham Laboratories.

Philab will roll out a precision medicine programme post acquisition, which will boost the synergies of the two companies in the healthcare sector.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology